![Novartis strikes deal with UK to provide cholesterol drug to high-risk patients](https://www.themediinfo.com/wp-content/uploads/2020/01/104545037-GettyImages-512309282-novartis.jpg)
A technician at the Novartis Institutes for BioMedical Research in Cambridge, Massachusetts.
David L. Ryan | The Boston Globe | Getty Images
Pharmaceutical giant Novartis has reached a deal with the U.K. government to provide its late-stage cholesterol drug, inclisiran, to patients at high risk of a heart attack, the company announced Monday.
The drug, which is pending approval in the U.S., will be provided on a “population basis” to patients with atherosclerosis in the U.K. once it is tested in a large clinical trial and approved for use there. Atherosclerosis is a devastating heart disease in which plaque builds up inside arteries and can lead to serious problems, including heart attack, stroke or death.
Inclisiran targets a protein called PCSK9 that is involved in producing LDL, or “bad” cholesterol. The drug is intended to be used in addition to statins for patients who struggle to lower cholesterol with traditional therapy.
“Novartis has a unique opportunity with inclisiran to open up a new chapter in the treatment of cardiovascular disease, the world’s leading cause of mortality and disability,” Novartis CEO Vas Narasimhan said in a statement. The company didn’t immediately release any financial details on the deal.
“We’re confident that innovative approaches like this will enable us to accelerate access timelines, deliver on our broader commitment to generating leading scientific evidence, and ensure continuous improvement in manufacturing efficiency and optimization,” he said.
Cardiovascular disease causes 46 times the number of deaths and 11 times the disease burden caused by AIDS, tuberculosis and malaria combined in Europe, according to the World Health Organization.
Novartis picked up the heart drug as part of its completed $9.7 billion acquisition of The Medicines Company, challenging Amgen’s Repatha and Sanofi’s and Regeneron’s Praluent, which target the same protein as inclisiran. The company expects to file the drug with European regulators in the first quarter of this year.
U.K. Health Secretary Matt Hancock said Monday that the deal is “a strong vote of confidence in our world-leading life sciences sector” that enables high-risk heart patients “to benefit from this potentially game-changing treatment.”
“I am committed to helping the NHS reach its full potential, and innovative collaborations such as this puts patients at the forefront of the most promising medical breakthroughs,” he added, referring to the U.K.’s National Health Service.
The deal was announced on the first day of the J.P. Morgan Healthcare Conference, the industry’s biggest investing event of the year, in San Francisco. More than 450 public and private companies in the biotech, pharmaceutical, insurance, hospital and medical device industries are expected to present at the four-day conference.
— CNBC’s Meg Tirrell and Jodi Gralnick contributed to this article.
Related Post
![Young Peoples Mental Health Is Finally G...](/featured/2024/04/1714368475_ce3afb1b0d708e4e8c36.webp)
Apr
Young Peoples Mental Health Is Finally Getting the Attention It Needs
The Coronavirus pandemic, a UNICEF report and a survey of the most recent exploration all feature the pressing requirement for better counteraction and treatment of youth nervousness and misery. Around the world, something like 13% of individuals between the ages of.
Read More![The Joy of Dancing: Mental Health Benefi...](/featured/2024/04/1713243358_f4f3966f340876ec8b4b.webp)
Apr
The Joy of Dancing: Mental Health Benefits
In this present reality where stress, nervousness, and misery are pervasive, tracking down viable and agreeable ways of advancing mental prosperity is foremost. While conventional types of treatment and drug assume significant parts in emotional wellness care, there exists an.
Read More![How You Can Beat the Odds by Getting Scr...](/featured/2024/04/1712725333_8f35fa3a125d8b82a424.jpg)
Apr
How You Can Beat the Odds by Getting Screened for Lung Cancer?
Cellular breakdown in the lungs is by a wide margin the deadliest malignant growth for people. The American Malignant growth Society predicts in excess of 230,000 Americans will be analyzed for the current year. Almost 130,000 will bite the dust.
Read More![Top 10 Health Benefits of Reflexology](/featured/2024/04/1712121604_9a92ab0babb4f2b4a571.jpg)
Apr
Top 10 Health Benefits of Reflexology
Did you realize reflexology is a back rub method that can be followed back to Old Egypt? Here of back rub, the strain is applied in unambiguous regions or zones in the hands and feet that associate to various pieces.
Read More